Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Immuno oncology treatment in head and neck cancer].
Dietz A, Stöhr M, Zebralla V, Pirlich M, Wichmann G, Wiegand S. Dietz A, et al. Among authors: pirlich m. Laryngorhinootologie. 2021 Apr;100(4):303-321. doi: 10.1055/a-1337-0882. Epub 2021 Mar 30. Laryngorhinootologie. 2021. PMID: 33784782 Review. German.
The Intelligent ENT Operating Room of the Future.
Pirlich M, Stöhr M, Neumuth T, Dietz A. Pirlich M, et al. Laryngorhinootologie. 2019 Mar;98(S 01):S5-S31. doi: 10.1055/a-0751-3537. Epub 2019 Apr 3. Laryngorhinootologie. 2019. PMID: 31096294 Free article. English, German.
Dysphagia, voice problems, and pain in head and neck cancer patients.
Zebralla V, Wichmann G, Pirlich M, Hammermüller C, Berger T, Zimmermann K, Neumuth T, Mehnert-Theuerkauf A, Dietz A, Hinz A, Wiegand S. Zebralla V, et al. Among authors: pirlich m. Eur Arch Otorhinolaryngol. 2021 Oct;278(10):3985-3994. doi: 10.1007/s00405-020-06584-6. Epub 2021 Jan 16. Eur Arch Otorhinolaryngol. 2021. PMID: 33452920 Free PMC article.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker.
Berszin M, Michaelides I, Siemert J, Röhl L, Wellhausen J, Wald T, Bohr C, Künzel J, Gradistanac T, Dietz A, Zebralla V, Pirlich M, Wiegand S, Wichmann G. Berszin M, et al. Among authors: pirlich m. Front Oncol. 2022 Feb 28;12:795277. doi: 10.3389/fonc.2022.795277. eCollection 2022. Front Oncol. 2022. PMID: 35296001 Free PMC article.
136 results